Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
53.4M
-
Shares change
-
-3.06M
-
Total reported value, excl. options
-
$872M
-
Value change
-
-$46.9M
-
Number of buys
-
61
-
Number of sells
-
-38
-
Price
-
$16.33
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q3 2022
129 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q3 2022.
Avidity Biosciences, Inc. - Common Stock (RNA) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
of 120M outstanding shares and own 44.43% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.17M shares), BlackRock Inc. (4.12M shares), COWEN AND COMPANY, LLC (3.79M shares), FMR LLC (3.47M shares), EcoR1 Capital, LLC (2.9M shares), T. Rowe Price Investment Management, Inc. (2.78M shares), VANGUARD GROUP INC (2.7M shares), Avidity Partners Management LP (2.6M shares), and FEDERATED HERMES, INC. (2.48M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.